Toggle Main Menu Toggle Search

Open Access padlockePrints

Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency

Lookup NU author(s): Professor Loranne Agius, Dr Brian FordORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Objective: Stable isotope studies have shown that hepatic de novo lipogenesis (DNL) plays an important role in the pathogenesis of intrahepatic lipid (IHL) deposition. Furthermore, previous research has demonstrated that fructose 1-phosphate (F1P) not only serves as a substrate for DNL, but also acts as a signalling metabolite that stimulates DNL from glucose. The aim of this study was to elucidate the mediators of F1P-stimulated DNL, with special focus on two key regulators of intrahepatic glucose metabolism, i.e., glucokinase regulatory protein (GKRP) and carbohydrate response element binding protein (ChREBP).Methods: Aldolase B deficient mice (Aldob-/-), characterized by hepatocellular F1P accumulation, enhanced DNL, and hepatic steatosis, were either crossed with GKRP deficient mice (Gckr-/-) or treated with short hairpin RNAs directed against hepatic ChREBP.Results: Aldob-/- mice showed higher rates of de novo palmitate synthesis from glucose when compared to wildtype mice (p < 0.001). Gckr knockout reduced de novo palmitate synthesis in Aldob-/- mice (p = 0.017), without affecting the hepatic mRNA expression of enzymes involved in DNL. In contrast, hepatic ChREBP knockdown normalized the hepatic mRNA expression levels of enzymes involved in DNL and reduced fractional DNL in Aldob-/- mice (p < 0.05). Of interest, despite downregulation of DNL in response to Gckr and ChREBP attenuation, no reduction in intrahepatic triglyceride levels was observed.Conclusions: Both GKRP and ChREBP mediate F1P-stimulated DNL in aldolase B deficient mice. Further studies are needed to unravel the role of GKRP and hepatic ChREBP in regulating IHL accumulation in aldolase B deficiency.


Publication metadata

Author(s): Buziau AM, Oosterveer MH, Wouters K, Bos T, Tolan DR, Agius L, Ford BE, Cassiman D, Stehouwer CDA, Schalkwijk CG, Brouwers MCGJ

Publication type: Article

Publication status: Published

Journal: Molecular Metabolism

Year: 2024

Volume: 87

Online publication date: 06/07/2024

Acceptance date: 02/07/2024

Date deposited: 18/07/2024

ISSN (electronic): 2212-8778

Publisher: Elsevier BV

URL: https://doi.org/10.1016/j.molmet.2024.101984

DOI: 10.1016/j.molmet.2024.101984

Data Access Statement: Data will be made available on request

PubMed id: 38972375


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Catalyst Grant from United for Metabolic Diseases ( UMD-CG-2022-015 ), which is financially supported by Metakids.
Dutch Society for the Study of Inborn Errors of Metabolism (Erfelijke Stofwisselingsziekten Nederland, ESN)
Dutch Diabetes Research Foundation (personal grant #2017.82.004 to MCGJB)
VIDI grant from the Dutch Scientific Organisation ( #91717373 )

Share